Journal of veterinary internal medicine2023; 37(3); 1250-1255; doi: 10.1111/jvim.16714

Concurrent chronic lymphocytic leukemia and primary hyperparathyroidism in a mule.

Abstract: A 26-year-old mule gelding was evaluated for chronic weight loss and decreased appetite. The mule had been losing weight and intermittently hypophagic for approximately 7 months. Laboratory analysis of whole blood and plasma identified severe total hypercalcemia, marked hypophosphatemia, markedly increased parathyroid hormone concentration, and marked lymphocytosis. A sestimibi scan intended to identify parathyroid gland tissue was nondiagnostic. Results of flow cytometry and PCR for antigen receptor rearrangement (PARR) were consistent with a B cell lymphoproliferative disorder, likely chronic lymphocytic leukemia (CLL). Although not previously described concurrently, these conditions may sometimes arise together, complicating definition of the underlying mechanism for weight loss and hypercalcemia in aged equids.
Publication Date: 2023-04-28 PubMed ID: 37118906PubMed Central: PMC10229365DOI: 10.1111/jvim.16714Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the case of a 26-year-old mule suffering from both chronic weight loss and decreased appetite, diagnosed with concurrent chronic lymphocytic leukemia (CLL) and primary hyperparathyroidism. These conditions, although previously unheard of together, may mutually arise leading to complications in determining the cause of weight loss and hypercalcemia in aged horses.

Clinical Evaluation and Diagnosis

  • The researchers investigated the causes of chronic weight loss and reduced appetite in a 26-year-old mule. These symptoms had been evident in the mule for about 7 months, raising concerns.
  • Through laboratory analysis of the mule’s whole blood and plasma, several abnormalities were found. These included severe hypercalcemia, marked lymphocytosis, hypophosphatemia and a significant increase in the parathyroid hormone concentration.
  • A sestimibi scan usually used to identify abnormalities in the parathyroid gland did not phase any positive results, leaving the causative conditions unclear at this stage.

Diagnosis Confirmation and Rarity of Condition

  • The researchers conducted flow cytometry and PCR for antigen receptor rearrangement (PARR) to probe deeper into the condition. These tests were suggestive of a B cell lymphoproliferative disorder, likely CLL.
  • The presence of both CLL and primary hyperparathyroidism in the mule is an unusual case. There aren’t previous descriptions of these conditions arising concurrently.

Implication for Aged Equids

  • This study suggests that aged equids, like the mule under observation, could suffer from both CLL and primary hyperparathyroidism concurrently.
  • These conditions could complicate the understanding of the exact causes of symptoms such as weight loss and hypercalcemia.

Cite This Article

APA
Townsend KS, Johnson PJ, Donnelly LL, LaCarrubba AM, Lattimer JC, Havis B, Springer NL, Kim DY. (2023). Concurrent chronic lymphocytic leukemia and primary hyperparathyroidism in a mule. J Vet Intern Med, 37(3), 1250-1255. https://doi.org/10.1111/jvim.16714

Publication

ISSN: 1939-1676
NlmUniqueID: 8708660
Country: United States
Language: English
Volume: 37
Issue: 3
Pages: 1250-1255

Researcher Affiliations

Townsend, Kile S
  • Department of Veterinary Medicine and Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA.
Johnson, Philip J
  • Department of Veterinary Medicine and Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA.
Donnelly, Lindsay L
  • Department of Veterinary Medicine and Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA.
LaCarrubba, Alison M
  • Department of Veterinary Medicine and Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA.
Lattimer, James C
  • Department of Veterinary Medicine and Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA.
Havis, Brett
  • Department of Veterinary Medicine and Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA.
Springer, Nora L
  • Department of Biomedical and Diagnostic Sciences, University of Tennessee, Knoxville, Tennessee, USA.
Kim, Dae Y
  • Department of Veterinary Medicine and Veterinary Medical Diagnostic Laboratory, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA.

MeSH Terms

  • Male
  • Horses
  • Animals
  • Leukemia, Lymphocytic, Chronic, B-Cell / complications
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell / veterinary
  • Equidae
  • Hypercalcemia / diagnosis
  • Hypercalcemia / veterinary
  • Hyperparathyroidism, Primary / diagnosis
  • Hyperparathyroidism, Primary / veterinary
  • Lymphocytosis / veterinary
  • Horse Diseases / diagnosis

Conflict of Interest Statement

Authors declare no conflict of interest.

References

This article includes 37 references
  1. Henneke DR, Potter GD, Kreider JL, Yeates BF. Relationship between condition score, physical measurements and body fat percentage in mares.. Equine Vet J 1983 Oct;15(4):371-2.
  2. Kamr AM, Dembek KA, Reed SM, Slovis NM, Zaghawa AA, Rosol TJ, Toribio RE. Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates.. PLoS One 2015;10(6):e0127684.
  3. Collar EM, Parker JE, Gorman EM, Russell DS, Valentine BA. PCR for antigen receptor rearrangement (PARR) clonality testing in a horse with a solitary retropharyngeal lymphoma. Equine Vet Educ J. 2019;31:413u2010418.
  4. Toribio RE. Parathyroid gland, calcium, and phosphorus regulation in horses. In: Smith BP, van Metre DC, Pusterla N, eds. Large Animal Internal Medicine. 6th ed. St. Louis: Elsevier; 2020:1376u20101386.
  5. Axiak S, Johnson PJ. Paraneoplastic manifestations of cancer in horses. Equine Vet Educ J. 2012;24:367u2010376.
  6. Barton MH, Sharma P, LeRoy BE, Howerth EW. Hypercalcemia and high serum parathyroid hormone-related protein concentration in a horse with multiple myeloma.. J Am Vet Med Assoc 2004 Aug 1;225(3):409-13, 376.
    pubmed: 15328717doi: 10.2460/javma.2004.225.409google scholar: lookup
  7. Meichner K, Kraszeski BH, Durrant JR, Grindem CB, Breuhaus BA, Moore PF, Neel JA, Linder KE, Borst LB, Fogle JE, Tarigo JL. Extreme lymphocytosis with myelomonocytic morphology in a horse with diffuse large B-cell lymphoma.. Vet Clin Pathol 2017 Mar;46(1):64-71.
    pubmed: 28001311doi: 10.1111/vcp.12435google scholar: lookup
  8. Wong D, Sponseller B, Miles K, Butt T, Kersh K, Myers R. Failure of Technetium Tc 99m sestamibi scanning to detect abnormal parathyroid tissue in a horse and a mule with primary hyperparathyroidism.. J Vet Intern Med 2004 Jul-Aug;18(4):589-93.
  9. Tomlinson JE, Johnson AL, Ross MW, Engiles JB, Levine DG, Wisner WA, Sweeney RW. Successful detection and removal of a functional parathyroid adenoma in a pony using technetium Tc 99m sestamibi scintigraphy.. J Vet Intern Med 2014 Mar-Apr;28(2):687-92.
    pmc: PMC4858011pubmed: 24417704doi: 10.1111/jvim.12285google scholar: lookup
  10. Cottle HJ, Hughes KJ, Thompson H, Johnston PEJ, Philbey AW. Primary hyperparathyroidism in a 17u2010yearu2010old Arab u00d7 Welsh Cob pony mare with a functional parathyroid adenoma. Equine Vet Educ J. 2016;28:477u2010485.
  11. Gorenberg EB, Johnson AL, Magdesian KG, Bertin FR, Costa LRR, Theelen MJP, Durward-Akhurst SA, Cruz Villagru00e1n C, Carslake H, Frank N, Tomlinson JE. Diagnosis and treatment of confirmed and suspected primary hyperparathyroidism in equids: 17 cases (1999-2016).. Equine Vet J 2020 Jan;52(1):83-90.
    pubmed: 30980730doi: 10.1111/evj.13120google scholar: lookup
  12. Schwarz B, Klang A, Schwendenwein I. Primary Hyperparathyroidism Associated With Atypical Headshaking Behavior in a Warmblood Gelding.. J Equine Vet Sci 2020 May;88:102840.
    pubmed: 32303315doi: 10.1016/j.jevs.2019.102840google scholar: lookup
  13. Brobst DF, Bayly WM, Reed SM, Howard GA, Torbeck RL. Parathyroid hormone evaluation in normal horses and horses with renal failure. J Equine Vet Sci. 1982;2:150u2010157.
  14. Elfers RS, Bayly WM, Brobst DF, Reed SM, Liggitt HD, Hawker CD, Baylink DJ. Alterations in calcium, phosphorus and C-terminal parathyroid hormone levels in equine acute renal disease.. Cornell Vet 1986 Jul;76(3):317-29.
    pubmed: 3731786
  15. Roussel AJ, Thatcher CD. Primary hyperparathyroidism in a pony mare. Compend Contin Educ Pract Vet. 1987;9:781u2010783.
  16. Colmer SF, Wulster K, Johnson AL, Levine DG, Underwood C, Watkins TW, Van Eps AW. Treatment of primary hyperparathyroidism in a Miniature Horse using chemical ablation of abnormal parathyroid tissue localized by 3-phase computed tomography.. J Vet Intern Med 2022 Mar;36(2):798-804.
    pmc: PMC8965272pubmed: 35150016doi: 10.1111/jvim.16390google scholar: lookup
  17. Matwichuk CL, Taylor SM, Daniel GB, Wilkinson AA, Matte GG, Dudzic EM, Shmon CL. Double-phase parathyroid scintigraphy in dogs using technetium-99M-sestamibi.. Vet Radiol Ultrasound 2000 Sep-Oct;41(5):461-9.
  18. Hillyar CR, Rizki H, Begum R, Gupta A, Nagabhushan N, Lee PH, Smith S. A Retrospective Cohort Study of the Utility of Ultrasound, 99mTc-Sestamibi Scintigraphy, and Four-Dimensional Computed Tomography for Pre-Operative Localization of Parathyroid Disease To Facilitate Minimally Invasive Parathyroidectomy.. Cureus 2022 Jan;14(1):e21177.
    pmc: PMC8837380pubmed: 35165625doi: 10.7759/cureus.21177google scholar: lookup
  19. Nichols KJ, Tomas MB, Tronco GG, Rini JN, Kunjummen BD, Heller KS, Sznyter LA, Palestro CJ. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings.. Radiology 2008 Jul;248(1):221-32.
    pubmed: 18483228doi: 10.1148/radiol.2481071066google scholar: lookup
  20. Greenspan BS, Dillehay G, Intenzo C, Lavely WC, O'Doherty M, Palestro CJ, Scheve W, Stabin MG, Sylvestros D, Tulchinsky M. SNM practice guideline for parathyroid scintigraphy 4.0.. J Nucl Med Technol 2012 Jun;40(2):111-8.
    pubmed: 22454482doi: 10.2967/jnmt.112.105122google scholar: lookup
  21. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.. Blood 2016 May 19;127(20):2375-90.
  22. Durham AC, Pillitteri CA, San Myint M, Valli VE. Two hundred three cases of equine lymphoma classified according to the World Health Organization (WHO) classification criteria.. Vet Pathol 2013 Jan;50(1):86-93.
    pubmed: 22700849doi: 10.1177/0300985812451603google scholar: lookup
  23. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Du00f6hner H, Hillmen P, Keating M, Montserrat E, Chiorazzi N, Stilgenbauer S, Rai KR, Byrd JC, Eichhorst B, O'Brien S, Robak T, Seymour JF, Kipps TJ. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.. Blood 2018 Jun 21;131(25):2745-2760.
    pubmed: 29540348doi: 10.1182/blood-2017-09-806398google scholar: lookup
  24. Dascanio JJ, Zhang CH, Antczak DF, Blue JT, Simmons TR. Differentiation of chronic lymphocytic leukemia in the horse. A report of two cases.. J Vet Intern Med 1992 Jul-Aug;6(4):225-9.
  25. Lester GD, Alleman AR, Raskin RE, Meyer JC. Pancytopenia secondary to lymphoid leukemia in three horses.. J Vet Intern Med 1993 Nov-Dec;7(6):360-3.
  26. McClure JT, Young KM, Fiste M, Sharkey LC, Lunn DP. Immunophenotypic classification of leukemia in 3 horses.. J Vet Intern Med 2001 Mar-Apr;15(2):144-52.
  27. Rendle DI, Durham AE, Thompson JC, Archer J, Mitchell M, Saunders K, Millere J, Paillot R, Smith KC, Kydd JH. Clinical, immunophenotypic and functional characterisation of T-cell leukaemia in six horses.. Equine Vet J 2007 Nov;39(6):522-8.
    pubmed: 18065310doi: 10.2746/042516407X2163271google scholar: lookup
  28. Cian F, Tyner G, Martini V, Comazzi S, Archer J. Leukemic small cell lymphoma or chronic lymphocytic leukemia in a horse.. Vet Clin Pathol 2013 Sep;42(3):301-6.
    pubmed: 23909896doi: 10.1111/vcp.12057google scholar: lookup
  29. Long AE, Javsicas LH, Stokol T, Felippe MJB, Frimberger AE. Rapid clinical progression of B-cell chronic lymphocytic leukemia in a horse.. J Am Vet Med Assoc 2019 Sep 15;255(6):716-721.
    pubmed: 31478818doi: 10.2460/javma.255.6.716google scholar: lookup
  30. Workman HC, Vernau W. Chronic lymphocytic leukemia in dogs and cats: the veterinary perspective.. Vet Clin North Am Small Anim Pract 2003 Nov;33(6):1379-99, viii.
    pubmed: 14664204doi: 10.1016/s0195-5616(03)00120-7google scholar: lookup
  31. Hallek M, Shanafelt TD, Eichhorst B. Chronic lymphocytic leukaemia.. Lancet 2018 Apr 14;391(10129):1524-1537.
    pubmed: 29477250doi: 10.1016/S0140-6736(18)30422-7google scholar: lookup
  32. Burkhard MJ, Bienzle D. Making Sense of Lymphoma Diagnostics in Small Animal Patients.. Clin Lab Med 2015 Sep;35(3):591-607.
    pubmed: 26297406doi: 10.1016/j.cll.2015.05.008google scholar: lookup
  33. Vallone LV, Neaderland MH, Ledbetter EC, Dubielzig RR. Suspected malignant transformation of B lymphocytes in the equine cornea from immune-mediated keratitis.. Vet Ophthalmol 2016 Mar;19(2):172-9.
    pubmed: 25919039doi: 10.1111/vop.12275google scholar: lookup
  34. Strewler GJ, Budayr AA, Clark OH, Nissenson RA. Production of parathyroid hormone by a malignant nonparathyroid tumor in a hypercalcemic patient.. J Clin Endocrinol Metab 1993 May;76(5):1373-5.
    pubmed: 7684395doi: 10.1210/jcem.76.5.7684395google scholar: lookup
  35. Iguchi H, Miyagi C, Tomita K, Kawauchi S, Nozuka Y, Tsuneyoshi M, Wakasugi H. Hypercalcemia caused by ectopic production of parathyroid hormone in a patient with papillary adenocarcinoma of the thyroid gland.. J Clin Endocrinol Metab 1998 Aug;83(8):2653-7.
    pubmed: 9709927doi: 10.1210/jcem.83.8.5025google scholar: lookup
  36. Nakajima K, Tamai M, Okaniwa S, Nakamura Y, Kobayashi M, Niwa T, Horigome N, Ito N, Suzuki S, Nishio S, Komatsu M. Humoral hypercalcemia associated with gastric carcinoma secreting parathyroid hormone: a case report and review of the literature.. Endocr J 2013;60(5):557-62.
    pubmed: 23303131doi: 10.1507/endocrj.ej12-0406google scholar: lookup
  37. Asonitis N, Angelousi A, Zafeiris C, Lambrou GI, Dontas I, Kassi E. Diagnosis, Pathophysiology and Management of Hypercalcemia in Malignancy: A Review of the Literature.. Horm Metab Res 2019 Dec;51(12):770-778.
    pubmed: 31826272doi: 10.1055/a-1049-0647google scholar: lookup

Citations

This article has been cited 0 times.